TY  - GEN
AU  - Palomo-Sanz, Concepcion
AU  - Mas-Lloret, Vicente
AU  - Thom, Michelle
AU  - Vazquez-Alcaraz, Monica
AU  - Cano, Olga
AU  - Terrón-Orellana, Maria Carmen
AU  - Luque, Daniel
AU  - Taylor, Geraldine
AU  - Melero, Jose Antonio
PY  - 2016
DO  - 10.1128/JVI.00338-16
UR  - http://hdl.handle.net/20.500.12105/17489
AB  - Human respiratory syncytial virus (hRSV) vaccine development has received new impetus from structure-based studies of its main protective antigen, the fusion (F) glycoprotein. Three soluble forms of F have been described: monomeric, trimeric...
LA  - eng
PB  - American Society for Microbiology (ASM)
KW  - Adjuvants, Immunologic
KW  - Animals
KW  - Antibodies, Neutralizing
KW  - Antibodies, Viral
KW  - Dose-Response Relationship, Immunologic
KW  - Epitopes
KW  - Female
KW  - Humans
KW  - Immunization
KW  - Immunogenicity, Vaccine
KW  - Lung
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Oligodeoxyribonucleotides
KW  - Protein Conformation
KW  - Recombinant Proteins
KW  - Respiratory Syncytial Virus Infections
KW  - Respiratory Syncytial Viruses
KW  - Viral Fusion Proteins
TI  - Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses
TY  - research article
ER  -